Three Different Types of Thermometers in Measuring Temperature in Young Patients With Fever and Without Fever
NCT ID: NCT00378846
Last Updated: 2012-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2006-03-31
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is studying three different types of thermometers to measure temperature in young patients with fever and without fever.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of a Novel Non-Invasive, Non-Touch Infrared Thermometer With Routine Thermometry in Routine Clinical Practice
NCT02805322
Clinical Evaluation of NIR (Non-Invasive Infrared) Thermometer Performance
NCT00760422
Evaluation of Infrared Cameras and Non-contact Infrared Thermometers for Measuring Body Temperatures
NCT04370743
Calibration and Validation of the Masimo Temperature Device in Febrile Patients
NCT05674344
Principles and Test Methods of Non-contact Body Thermometry
NCT05247736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary
* Determine agreement between three different types of temperature-measuring instruments: the temporal artery scanner, the digital oral thermometer, and the infrared tympanic thermometer calibrated to an oral setting, in pediatric patients who are febrile and afebrile.
Secondary
* Determine similarities or differences in the percent of fevers detected with oral, ear, and temporal artery monitoring in these pediatric patients.
* Determine differences in agreement of the various temperature devices in non-neutropenic pediatric patients versus neutropenic pediatric patients.
OUTLINE: This is a prospective study.
During an afebrile episode, the patient's temperature is measured twice using the following 3 devices: a temporal artery scanner, a digital oral thermometer, and an infrared tympanic thermometer calibrated to an oral setting (total of 6 temperature measurements per afebrile episode).
During a febrile episode, the patient's temperature is measured twice using all 3 devices as above, and then at 2 and 4 hours after administration of an antipyretic medication (total of 18 temperatures per febrile episode).
Patients' temperatures are recorded for a maximum of 3 afebrile or febrile episodes.
PROJECTED ACCRUAL: A total of 32 patients will be accrued for this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
DIAGNOSTIC
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
infrared thermography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Febrile or afebrile
* Patient at the Mark O. Harfield Clinical Research Center
* Previously enrolled in an IRB-approved Clinical Center protocol
PATIENT CHARACTERISTICS:
* Able to hold an oral thermometer in mouth
* No acute life-threatening infection
* No ear, nose, or throat (aural) abnormalities
* No severe mucositis
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No concurrent enrollment on a behavioral research study
4 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
National Institutes of Health Clinical Center (CC)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas J. Walsh, MD
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute (NCI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-C-0118
Identifier Type: -
Identifier Source: secondary_id
NCI-P6842
Identifier Type: -
Identifier Source: secondary_id
CDR0000496917
Identifier Type: -
Identifier Source: secondary_id
060118
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.